Walter G. Espeche

ORCID: 0000-0003-1671-5601
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Heart Rate Variability and Autonomic Control
  • Maternal and fetal healthcare
  • Sodium Intake and Health
  • Cardiovascular Health and Disease Prevention
  • Obesity, Physical Activity, Diet
  • Health and Lifestyle Studies
  • Medication Adherence and Compliance
  • Lipoproteins and Cardiovascular Health
  • Liver Disease Diagnosis and Treatment
  • Global Public Health Policies and Epidemiology
  • Gestational Diabetes Research and Management
  • Hemodynamic Monitoring and Therapy
  • Adipokines, Inflammation, and Metabolic Diseases
  • Climate Change and Health Impacts
  • Healthcare Systems and Public Health
  • COVID-19 Clinical Research Studies
  • Trauma and Emergency Care Studies
  • Academic Writing and Publishing
  • Health Promotion and Cardiovascular Prevention
  • Cardiovascular Function and Risk Factors
  • Dialysis and Renal Disease Management

Universidad Nacional de La Plata
2014-2025

St Martin's Hospital
2022-2025

Hospital de Clínicas "José de San Martín"
2019-2024

Hospital Italiano La Plata
2011-2024

National University of General San Martín
2012-2023

Ministerio de Salud - Provincia de Buenos Aires
2021

Hospital Universitario Austral
2014

Thomas Beaney Louise M. Burrell Rafael R. Castillo Fadi J. Charchar Suzie Cro and 95 more Albertino Damasceno Ruan Kruger Peter M Nilsson Dorairaj Prabhakaran Agustín J. Ramiréz Markus P. Schlaich Aletta E. Schutte Maciej Tomaszewski Rhian M. Touyz Ji-Guang Wang Michael A. Weber Neil R Poulter Genc Burazeri Gentiana Qirjako Enver Roshi Rudina Cunashi Mario J C C Fernandes Savarino S Victória Pereira Marisa F M P Neto Pombalino N M Oliveira Ana C G Feijão Yamila Cerniello Marcos J. Marín Fortunato García Vásquez Walter G. Espeche Diego Stisman Inés A Fuentes Juith M Zilberman P. Rodríguez Carnero Kamsar Yu Babinyan Anna H Engibaryan Avag Avagyan Arsen Minasyan A. Gevorkyan Revathy Carnagarin M. Carrington James E. Sharman Rebecca Lee Sabine Perl Ella Niederl Fazila‐Tun‐Nesa Malik Sohel Reza Choudhury Mohammad Al Mamun Mir Ishraquzzaman Fiona Anthony Kenneth Connell Tine De Backer Jea Krzesinski Martin Houénassi Corine Houéhanou Dragan Lović Rankica Bahtijarevic Mary Banyana Tiro Mosepele Mosepele Tiny Masupe Weimar Kunz Sebba Barroso Marco Antônio Mota Gomes Audes D. M. Feitosa Andréa Araújo Brandão Roberto Dischinger Miranda Vanda Azevedo Luis M Dias Glenda Garcia Idiana P P Martins Anastase Dzudié Samuel Kingué F Djomou Epie Njume Nadia Khan Fernando Laņas María Soledad Fernández García Mélanie Paccot Pamela Torres Yan Li Min Liu Liying Xu Li Li Xin Chen Junping Deng Wenwu Zhao Lingjuan Fu Yi Zhou Patricio López‐Jaramillo Johanna Otero Paul Anthony Camacho José Accini Gregorio Sánchez Édgar Arcos Jean-René M’Buyamba-Kabangu Fortunat K Katamba Georges N Ngoyi Nathan M Buila Pascal Bayauli Bertrand Fikahem Ellenga Mbolla Paterne R Bakekolo

Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide fewer than half of those with hypertension are aware it. May Measurement Month (MMM) a global campaign set up in 2017, raise awareness high BP as pragmatic solution lack formal screening worldwide. The 2018 was expanded, aiming include more participants countries.

10.1093/eurheartj/ehz300 article EN cc-by-nc European Heart Journal 2019-04-25

Elevated blood pressure remains the single biggest risk factor contributing to global burden of disease and mortality. May Measurement Month is an annual screening campaign aiming improve awareness at individual population level. Adults (≥18 years) recruited through opportunistic sampling were screened sites in 92 countries during 2019. Ideally, 3 readings measured for each participant, data on lifestyle factors comorbidities collected. Hypertension was defined as a systolic ≥140 mm Hg, or...

10.1161/hypertensionaha.120.14874 article EN cc-by-nc Hypertension 2020-05-18

Abstract Background Metabolic syndrome (MetS) has been shown to predict both risk and CVD events. We have identified sex‐specific values for the triglyceride/high‐density lipoprotein cholesterol ( TG / HDL ‐C) ratio associated with an unfavourable cardio‐metabolic profile, but it is not known whether also predicts outcome. Methods To quantify outcomes a high TG/HDL‐C compare this that predicted using MetS, population longitudinal prospective observational study was performed in Rauch City,...

10.1111/joim.12036 article EN Journal of Internal Medicine 2013-02-18

This study compares the ability of an elevated triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio, using sex-specific cut-points, to identify insulin-resistant individuals within a population without known cardiac disease or diabetes with that obtained diagnostic criteria metabolic syndrome (MetS). Measurements were made waist circumference (WC), systolic and diastolic blood pressure, fasting plasma glucose, insulin (FPI), TG HDL-C concentrations in 1102 women 464 men. These...

10.1177/1479164113479809 article EN Diabetes and Vascular Disease Research 2013-04-26

The aim of this study is to test the hypotheses that: 1) diagnosing metabolic syndrome does not effectively identify insulin-resistant (IR) individuals; and 2) waist circumference (WC) no better than body mass index (BMI) in predicting insulin resistance or components (MetS). Measurements BMI, WC, blood pressure, fasting plasma glucose, (FPI), triglycerides (TG), HDL-cholesterol (HDL-C) concentrations were made 1,300 adults, without known cardiovascular disease (CVD) drug treatment...

10.1177/1479164111403170 article EN Diabetes and Vascular Disease Research 2011-04-01

The aim was to evaluate the prevalence of nocturnal and masked hypertension prognostic values these blood pressure (BP) abnormalities in normotensive women coursing a high-risk pregnancy.The study performed pregnant with 20 or more weeks gestation pregnancy, sent specialized department perform prospective defined protocol BP evaluation. Women office at least 140/90 mmHg were excluded. An ambulatory monitoring identify (defined according current guidelines). adjusted risk for development...

10.1097/hjh.0000000000001067 article EN Journal of Hypertension 2016-08-09

Objectives: To estimate the prevalence of isolated nocturnal hypertension (INH) and its relationships with office blood pressure (BP) categories defined by 2018 ESC/ESH guidelines. Methods: We conducted a prospective cohort study in consecutive patients referred to perform an ambulatory monitoring (ABPM) for diagnosis or therapeutic purposes. Office BP measurements ABPM were performed same visit. The was divided according optimal, normal, high-normal hypertension. adjusted risk combined...

10.1097/hjh.0000000000002278 article EN Journal of Hypertension 2019-10-04

The aim of this study was to test if hypertension detected by ambulatory blood pressure monitoring (ABPM) performed at mid-pregnancy, is a useful predictor for preeclampsia/eclampsia (PEEC).The in women coursing high-risk mid-pregnancies. Office (BP) estimated as the mean three values, taken specialized nurse after 15-min interview, and office defined least 140/90 mmHg. Immediately after, an ABPM started. Diurnal 135/85 mmHg during daily activities, nocturnal 120/70 night rest. adjusted risk...

10.1097/hjh.0000000000001848 article EN Journal of Hypertension 2018-07-16

Objective: The aim of this study was to characterize individuals with nondipping heart rate (HR) and assess the association between that pattern sleep quality during night an ambulatory blood pressure monitoring (ABPM). Methods: Individuals who attended our Unit perform ABPM, from February 2022 May 2024, were asked about clinical epidemiological antecedents responded two validated surveys, ABPM in prior 30 days. Then, they categorized according presence a dipping nocturnal HR (defined as...

10.1097/hjh.0000000000003971 article EN Journal of Hypertension 2025-02-03

<title>Abstract</title> To investigate the relationship between blood pressure (BP) components (daytime vs. nocturnal BP and systolic diastolic BP) preeclampsia (PE) across gestational stages. We conducted a historical cohort study involving 1,363 high-risk pregnant women (mean age, 30 ± 7 years). Ambulatory monitoring (ABPM) was performed at 12–19 weeks (n = 389), 20–27 798), 28–36 1,176); 59.9%, 25.0%, 15.1% of participants underwent one, two, three ABPM evaluations, respectively. PE...

10.21203/rs.3.rs-6141125/v1 preprint EN cc-by Research Square (Research Square) 2025-03-31

The aim of this study was to test the hypothesis that cardiovascular disease occurs greatest extent in persons with prediabetes mellitus who are also insulin resistant. In 2003, 664 non-diabetic women (n = 457) and men 207), aged 52 ± 16 53 15 years, were surveyed during a programme for prevention. Fasting plasma glucose concentrations defined participants as having normal fasting (fasting <5.6 mmol/L) or ⩾ 5.6 <7.0 mmol/L). tertile subjects highest concentration classified Baseline risk...

10.1177/1479164115610057 article EN Diabetes and Vascular Disease Research 2016-01-22

To determine if there is an office blood pressure (BP) value below which out-of-office measurements are unnecessary in high-risk pregnant women.We conducted a prospective cohort study women the second half of pregnancies. Office BP and ambulatory monitoring (ABPM) was performed. The divided according to quartiles normotension, white-coat hypertension, masked hypertension sustained hypertension. risks for preeclampsia/eclampsia each category were estimated.Three hundred seventy-three (30 ± 7...

10.1097/hjh.0000000000002140 article EN Journal of Hypertension 2019-06-05

Aims: To evaluate arterial stiffness indicators in people with prediabetes (PreD) and its possible pathogenesis. Materials methods: Pulse wave velocity (PWV) was measured 208 FINDRISC ≥ 13 (57 ± 8 years old, 68.7% women) thereafter divided into those having either normal glucose tolerance (NGT) or PreD. In each subgroup we also identified with/out insulin resistance (IR) by the triglyceride/HDL-c ratio (normal cut off values previously established our population). Clinical metabolic data...

10.3390/jcm10153251 article EN Journal of Clinical Medicine 2021-07-23

There is evidence that the plasma concentration ratio of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) identifies insulin resistance and increased cardiometabolic risk outcome in apparently healthy individuals. Since use TG/HDL-C to accomplish this task persons over a wide range adiposity has not been studied, ability previously defined sex-specific cut-points identify was evaluated normal weight, overweight, obese Data were analyzed from population-based study men (n=416)...

10.1136/jim-2016-000248 article EN Journal of Investigative Medicine 2016-09-17
Coming Soon ...